FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996860050> ?p ?o ?g. }

• W1996860050 endingPage "203" @default.
• W1996860050 startingPage "198" @default.
• W1996860050 abstract "Antisense oligonucleotide-mediated alternative splicing has great potential for treatment of Duchenne muscular dystrophy (DMD) caused by mutations within nonessential regions of the dystrophin gene. We have recently shown in the dystrophic mdx mouse that exon 23, bearing a nonsense mutation, can be skipped after intramuscular injection of a specific 2′- O -methyl phosphorothioate antisense oligoribonucleotide (2OMeAO). This skipping created a shortened, but in-frame, transcript that is translated to produce near-normal levels of dystrophin expression. This expression, in turn, led to improved muscle function. However, because DMD affects muscles body-wide, effective treatment requires dystrophin induction ideally in all muscles. Here, we show that systemic delivery of specific 2OMeAOs, together with the triblock copolymer F127, induced dystrophin expression in all skeletal muscles but not in cardiac muscle of the mdx dystrophic mice. The highest dystrophin expression was detected in diaphragm, gastrocnemius, and intercostal muscles. Large numbers of fibers with near-normal level of dystrophin were observed in focal areas. Three injections of 2OMeAOs at weekly intervals enhanced the levels of dystrophin. Dystrophin mRNA lacking the targeted exon 23 remained detectable 2 weeks after injection. No evidence of tissue damage was detected after 2OMeAO and F127 treatment either by serum analysis or histological examination of liver, kidney, lung, and muscles. The simplicity and safety of the antisense protocol provide a realistic prospect for treatment of the majority of DMD mutations. We conclude that a significant therapeutic effect may be achieved by further optimization in dose and regime of administration of antisense oligonucleotide." @default.
• W1996860050 created "2016-06-24" @default.
• W1996860050 creator A5000657142 @default.
• W1996860050 creator A5005899114 @default.
• W1996860050 creator A5006600392 @default.
• W1996860050 creator A5020667221 @default.
• W1996860050 creator A5030292211 @default.
• W1996860050 creator A5055891535 @default.
• W1996860050 creator A5075504414 @default.
• W1996860050 creator A5089226238 @default.
• W1996860050 creator A5091081425 @default.
• W1996860050 date "2004-12-17" @default.
• W1996860050 modified "2023-10-16" @default.
• W1996860050 title "Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles" @default.
• W1996860050 cites W1510860002 @default.
• W1996860050 cites W1964278976 @default.
• W1996860050 cites W1966493859 @default.
• W1996860050 cites W1993785908 @default.
• W1996860050 cites W2002703021 @default.
• W1996860050 cites W2023691430 @default.
• W1996860050 cites W2026728314 @default.
• W1996860050 cites W2034387481 @default.
• W1996860050 cites W2038491737 @default.
• W1996860050 cites W2040743013 @default.
• W1996860050 cites W2058807250 @default.
• W1996860050 cites W2064605119 @default.
• W1996860050 cites W2066180106 @default.
• W1996860050 cites W2067671642 @default.
• W1996860050 cites W2072847969 @default.
• W1996860050 cites W2081342237 @default.
• W1996860050 cites W2083862437 @default.
• W1996860050 cites W2098051622 @default.
• W1996860050 cites W2110154453 @default.
• W1996860050 cites W2139646940 @default.
• W1996860050 cites W2324487866 @default.
• W1996860050 doi "https://doi.org/10.1073/pnas.0406700102" @default.
• W1996860050 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/544058" @default.
• W1996860050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15608067" @default.
• W1996860050 hasPublicationYear "2004" @default.
• W1996860050 type Work @default.
• W1996860050 sameAs 1996860050 @default.
• W1996860050 citedByCount "363" @default.
• W1996860050 countsByYear W19968600502012 @default.
• W1996860050 countsByYear W19968600502013 @default.
• W1996860050 countsByYear W19968600502014 @default.
• W1996860050 countsByYear W19968600502015 @default.
• W1996860050 countsByYear W19968600502016 @default.
• W1996860050 countsByYear W19968600502017 @default.
• W1996860050 countsByYear W19968600502018 @default.
• W1996860050 countsByYear W19968600502019 @default.
• W1996860050 countsByYear W19968600502020 @default.
• W1996860050 countsByYear W19968600502021 @default.
• W1996860050 countsByYear W19968600502022 @default.
• W1996860050 countsByYear W19968600502023 @default.
• W1996860050 crossrefType "journal-article" @default.
• W1996860050 hasAuthorship W1996860050A5000657142 @default.
• W1996860050 hasAuthorship W1996860050A5005899114 @default.
• W1996860050 hasAuthorship W1996860050A5006600392 @default.
• W1996860050 hasAuthorship W1996860050A5020667221 @default.
• W1996860050 hasAuthorship W1996860050A5030292211 @default.
• W1996860050 hasAuthorship W1996860050A5055891535 @default.
• W1996860050 hasAuthorship W1996860050A5075504414 @default.
• W1996860050 hasAuthorship W1996860050A5089226238 @default.
• W1996860050 hasAuthorship W1996860050A5091081425 @default.
• W1996860050 hasBestOaLocation W19968600502 @default.
• W1996860050 hasConcept C104317684 @default.
• W1996860050 hasConcept C134018914 @default.
• W1996860050 hasConcept C153911025 @default.
• W1996860050 hasConcept C194583182 @default.
• W1996860050 hasConcept C2778750056 @default.
• W1996860050 hasConcept C2778776201 @default.
• W1996860050 hasConcept C2778943923 @default.
• W1996860050 hasConcept C2779030066 @default.
• W1996860050 hasConcept C2779959927 @default.
• W1996860050 hasConcept C2780394045 @default.
• W1996860050 hasConcept C36823959 @default.
• W1996860050 hasConcept C501734568 @default.
• W1996860050 hasConcept C54355233 @default.
• W1996860050 hasConcept C71924100 @default.
• W1996860050 hasConcept C75563809 @default.
• W1996860050 hasConcept C78343239 @default.
• W1996860050 hasConcept C86803240 @default.
• W1996860050 hasConcept C95444343 @default.
• W1996860050 hasConcept C96777560 @default.
• W1996860050 hasConceptScore W1996860050C104317684 @default.
• W1996860050 hasConceptScore W1996860050C134018914 @default.
• W1996860050 hasConceptScore W1996860050C153911025 @default.
• W1996860050 hasConceptScore W1996860050C194583182 @default.
• W1996860050 hasConceptScore W1996860050C2778750056 @default.
• W1996860050 hasConceptScore W1996860050C2778776201 @default.
• W1996860050 hasConceptScore W1996860050C2778943923 @default.
• W1996860050 hasConceptScore W1996860050C2779030066 @default.
• W1996860050 hasConceptScore W1996860050C2779959927 @default.
• W1996860050 hasConceptScore W1996860050C2780394045 @default.
• W1996860050 hasConceptScore W1996860050C36823959 @default.
• W1996860050 hasConceptScore W1996860050C501734568 @default.
• W1996860050 hasConceptScore W1996860050C54355233 @default.
• W1996860050 hasConceptScore W1996860050C71924100 @default.

• next